Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	645	379	250	7	134	160
Market Cap Growth	108.14%	51.72%	3402.67%	-94.66%	-16.71%	80.14%
Enterprise Value	692	402	246	2	102	124
Last Close Price	0.10	0.08	0.05	0.00	0.10	0.12
PE Ratio	-	-	-	-	-	55.59
PS Ratio	11.72	6.88	4.53	0.12	1.84	1.90
PB Ratio	-22.87	-13.44	33.95	3.45	3.54	3.31
P/TBV Ratio	-	-	93.58	-	4.08	3.67
P/FCF Ratio	-	-	-	-	-	26.62
P/OCF Ratio	-	-	-	-	-	18.68
PEG Ratio	-	5.65	5.65	5.65	5.65	5.65
EV/Sales Ratio	12.57	7.30	4.46	0.03	1.40	1.47
EV/EBITDA Ratio	-	-	-	-	-	20.31
EV/EBIT Ratio	-	-	-	-	-	31.62
EV/FCF Ratio	-22.06	-	-	-	-	20.60
Debt / Equity Ratio	-2.13	-2.13	4.21	17.42	0.28	0.23
Debt / EBITDA Ratio	-	-	-	-	-	1.44
Debt / FCF Ratio	-	-	-	-	-	1.85
Asset Turnover	0.82	0.82	0.83	0.85	0.90	0.97
Inventory Turnover	1.93	1.93	2.09	2.29	2.09	2.11
Quick Ratio	0.69	0.69	1.02	1.07	1.46	2.46
Current Ratio	1.27	1.27	1.78	1.81	2.35	3.17
Return on Equity (ROE)	-	-	-819.81%	-216.27%	-31.93%	6.25%
Return on Assets (ROA)	-26.58%	-26.58%	-32.23%	-31.48%	-9.60%	2.81%
Return on Invested Capital (ROIC)	-149.09%	-127.92%	-141.18%	-138.02%	-52.41%	16.12%
Return on Capital Employed (ROCE)	-70.60%	-70.60%	-72.10%	-73.00%	-22.50%	5.60%
Earnings Yield	-6.22%	-10.59%	-15.46%	-604.03%	-10.31%	1.80%
FCF Yield	-4.87%	-8.28%	-14.23%	-470.51%	-12.76%	3.76%
Buyback Yield / Dilution	-27.33%	-27.33%	-458.41%	-4.26%	4.98%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.